WP_Query Object
(
[query] => Array
(
[post_type] => post
[posts_per_page] => 3
[post_status] => publish
[orderby] => rand
)
[query_vars] => Array
(
[post_type] => post
[posts_per_page] => 3
[post_status] => publish
[orderby] => rand
[error] =>
[m] =>
[p] => 0
[post_parent] =>
[subpost] =>
[subpost_id] =>
[attachment] =>
[attachment_id] => 0
[name] =>
[pagename] =>
[page_id] => 0
[second] =>
[minute] =>
[hour] =>
[day] => 0
[monthnum] => 0
[year] => 0
[w] => 0
[category_name] =>
[tag] =>
[cat] =>
[tag_id] =>
[author] =>
[author_name] =>
[feed] =>
[tb] =>
[paged] => 0
[meta_key] =>
[meta_value] =>
[preview] =>
[s] =>
[sentence] =>
[title] =>
[fields] => all
[menu_order] =>
[embed] =>
[category__in] => Array
(
)
[category__not_in] => Array
(
)
[category__and] => Array
(
)
[post__in] => Array
(
)
[post__not_in] => Array
(
)
[post_name__in] => Array
(
)
[tag__in] => Array
(
)
[tag__not_in] => Array
(
)
[tag__and] => Array
(
)
[tag_slug__in] => Array
(
)
[tag_slug__and] => Array
(
)
[post_parent__in] => Array
(
)
[post_parent__not_in] => Array
(
)
[author__in] => Array
(
)
[author__not_in] => Array
(
)
[search_columns] => Array
(
)
[ignore_sticky_posts] =>
[suppress_filters] =>
[cache_results] => 1
[update_post_term_cache] => 1
[update_menu_item_cache] =>
[lazy_load_term_meta] => 1
[update_post_meta_cache] => 1
[nopaging] =>
[comments_per_page] => 50
[no_found_rows] =>
[order] =>
)
[tax_query] => WP_Tax_Query Object
(
[queries] => Array
(
)
[relation] => AND
[table_aliases:protected] => Array
(
)
[queried_terms] => Array
(
)
[primary_table] => wp_posts
[primary_id_column] => ID
)
[meta_query] => WP_Meta_Query Object
(
[queries] => Array
(
)
[relation] =>
[meta_table] =>
[meta_id_column] =>
[primary_table] =>
[primary_id_column] =>
[table_aliases:protected] => Array
(
)
[clauses:protected] => Array
(
)
[has_or_relation:protected] =>
)
[date_query] =>
[request] => SELECT SQL_CALC_FOUND_ROWS wp_posts.ID
FROM wp_posts
WHERE 1=1 AND wp_posts.post_type = 'post' AND ((wp_posts.post_status = 'publish'))
ORDER BY RAND()
LIMIT 0, 3
[posts] => Array
(
[0] => WP_Post Object
(
[ID] => 5065
[post_author] => 4
[post_date] => 2026-09-01 14:03:32
[post_date_gmt] => 2026-09-01 18:03:32
[post_content] =>
Applications are now open for the 12th BioREACH Award Program from the Center for Biotechnology, which provides $50,000 in translational research funding for Stony Brook faculty and postdoctoral researchers to generate the evidence needed to advance promising innovations to the next stage of development.
BioREACH funds milestone-driven studies and welcomes biomedical innovations as well as platforms, tools, computational technologies, and other enabling technologies with the potential to contribute to solutions addressing unmet needs in health.
Application deadline: October 29, 2026, 5:00pm ET
For info sessions, eligibility and deadlines visit our REACH Website and FAQ.
The Center for Biotechnology (CfB) has helped advance some of Stony Brook University’s most impactful biomedical innovations, among them the yeast two-hybrid system, Xiaflex®, ReoPro®, Oracea®, and 3D virtual colonoscopy. The CfB has supported more than 475 faculty-led translational research projects and contributed to 306 license agreements generating $51 million in royalty returns to the University.
Questions? Reach out to our program contacts or sign up for office hours:
Dee Dao, PhD, Associate Director, dee.dao@stonybrook.edu
Office Hours: Monday–Friday, 2–3:30 PM | Sign up Here
Zelda Mendelowitz, PhD, Venture Associate, zelda.mendelowitz@stonybrook.edu
Office Hours: Tuesday, Wednesday, Friday, 8–11 AM | Sign up Here
[post_title] => BioREACH: Translational Research Funding Opportunity
[post_excerpt] =>
[post_status] => publish
[comment_status] => open
[ping_status] => open
[post_password] =>
[post_name] => bioreach-translational-research-funding-opportunity
[to_ping] =>
[pinged] =>
[post_modified] => 2026-09-04 11:55:36
[post_modified_gmt] => 2026-09-04 15:55:36
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://centerforbiotechnology.org/?p=5065
[menu_order] => 0
[post_type] => post
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[1] => WP_Post Object
(
[ID] => 3083
[post_author] => 3
[post_date] => 2018-11-16 14:26:57
[post_date_gmt] => 2018-11-16 14:26:57
[post_content] => Update courtesy of BBC Entrepreneurial Training and Consulting
NIH is strongly encouraging small businesses to contact the appropriate Institute or Center early in their application planning to ensure their technology is a priority for the Institute/Center.
An updated SBIR/STTR Application Guide with additional instructions for SBIR Direct Phase II application preparation and submission will be posted by November 26, 2018. The following sections of each FOA are changed:
Part 2, Section I. Funding Opportunity Description The following has been added at the end of the section for each FOA:
PA-18-573 The following Components will not accept an SBIR Direct-to-Phase II submission:
- National Institute of Nursing Research (NINR)
- National Center for Complementary and Integrative Health (NCCIH)
PA-18-574 The following Components will not accept an SBIR Direct-to-Phase II submission:
- National Institute of Environmental Health Sciences (NIEHS )
- National Institute of Nursing Research (NINR)
- National Center for Complementary and Integrative Health (NCCIH)
- Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs (ORIP)
- Centers for Disease Control and Prevention (CDC) (All Components of CDC)
- U.S. Food and Drug Administration (FDA) (All Components of FDA)
Part 2, Section II. Award Information for both PA-18-573 and PA-18-574. Application types now allowed are:
- New (Phase I, Fast-Track)
- New (Direct Phase II)
- Renewal (Phase II)
- Resubmission (all phases)
- Phase IIB Competing Renewal (Phase IIB)
- Revision
The OER Glossary and the SF424 (R&R) SBIR/STTR Application Guide provide details on these application types.
[post_title] => Important SBIR/STTR Information Update from NIH
[post_excerpt] => An updated SBIR/STTR Application Guide with additional instructions for SBIR Direct Phase II application preparation and submission will be posted by November 26, 2018.
[post_status] => publish
[comment_status] => open
[ping_status] => open
[post_password] =>
[post_name] => important-sbirsttr-information-update-from-nih
[to_ping] =>
[pinged] =>
[post_modified] => 2018-11-16 14:26:57
[post_modified_gmt] => 2018-11-16 14:26:57
[post_content_filtered] =>
[post_parent] => 0
[guid] => http://centerforbiotechnology.org/?p=3083
[menu_order] => 110
[post_type] => post
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[2] => WP_Post Object
(
[ID] => 3462
[post_author] => 3
[post_date] => 2020-03-18 11:02:50
[post_date_gmt] => 2020-03-18 11:02:50
[post_content] => BARDA is calling for biomedical innovations to tackle COVID-19 pandemic through two major solilications. EZ-BAA solicitations for funding up to $750K, and BAA (no funding limit).
Deadline for EZ-BAA submission is June 30th. Innovations are sought for multiple areas (.e. molecular assays, point-of-care diagnostics, vaccines, therapeutics, manufacturing platform, devices, ventilators.) Innovators are encouraged to review the most updated proposal solicitations through the links below:
EZ BAA: https://beta.sam.gov/opp/b4f7923443a448218d369209723141c5/view
BARDA BAA: https://beta.sam.gov/opp/1b46a4169fcb4902b9c4fcbb5bf981f7/view
Innovators are also welcome to submit quick applications to this market research portal on COVID-19 which are frequently reviewed by an inter-agency task force committee, including CDC, HHS, and NIH:
https://www.medicalcountermeasures.gov/app/barda/coronavirus.aspx
If you have any questions regarding your technology and how to engage with BARDA, Please contact Phuong Nguyen at the Center for Biotechnology for help: phuong.t.nguyen@stonybrook.edu
[post_title] => BARDA: Call for innovations to tackle COVID-19
[post_excerpt] => BARDA is calling for biomedical innovations to tackle COVID-19 pandemic through two major solilications. EZ-BAA solicitations for funding up to $750K, and BAA (no funding limit).
[post_status] => publish
[comment_status] => open
[ping_status] => open
[post_password] =>
[post_name] => barda-call-for-innovations-to-tackle-covid-19
[to_ping] =>
[pinged] =>
[post_modified] => 2020-03-18 11:02:50
[post_modified_gmt] => 2020-03-18 11:02:50
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://centerforbiotechnology.org/?p=3462
[menu_order] => 73
[post_type] => post
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[3] => WP_Post Object
(
[ID] => 1493
[post_author] => 3
[post_date] => 2015-04-08 19:48:55
[post_date_gmt] => 2015-04-08 19:48:55
[post_content] => Gaurav Lalwani, PhD, Biomedical Engineering department at Stony brook University and Center for Biotechnology Fundamentals Program alumnus, has Co-founded Millennial Materials and Devices, a company which was recently awarded second place in the Stony Brook Entrepreneurs Challenge 2015, with a cash reward of $10,000 and $3000 prize in 'DARE to RISK' Business Plan Competition at Farmingdale State University, Long Island Regional Affiliate of the New York State Business Plan.
Millennial Materials will now be presenting at the Finals of New York Business Plan Competition (NYBPC) in Albany on April 24, 2015 in the Nanotechnology/Advanced Technology category. The NYBPC is the only leading collegiate business competition that is a regionally coordinated, collaborative statewide program representing over 75 colleges and universities, which sets it apart from all other competitions in the nation. Millennial Materials and Devices is working towards the commercialization of a novel proprietary formulation and method to fabricate large-area transparent conductive films for applications ranging from the fabrication of flexible unbreakable displays to electromagnetic shielding and biomedical coatings.
[post_title] => Millennial Materials and Devices Presenting at NY Business Plan Competition Finals
[post_excerpt] => Millennial Materials and Devices, co-founded by BME and FOBIP Alumnus, will be presenting in the finals of New York Business Plan Competition (NYBPC) after placing in the Stony Brook Entrepreneurs Challenge 2015.
[post_status] => publish
[comment_status] => open
[ping_status] => open
[post_password] =>
[post_name] => millennial-materials-and-devices-presenting-at-the-finals-of-ny-business-plan-competition
[to_ping] =>
[pinged] =>
[post_modified] => 2016-03-02 17:49:09
[post_modified_gmt] => 2016-03-02 17:49:09
[post_content_filtered] =>
[post_parent] => 0
[guid] => http://centerforbiotechnology.org/new/?p=1493
[menu_order] => 206
[post_type] => post
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
)
[post_count] => 4
[current_post] => -1
[before_loop] => 1
[in_the_loop] =>
[post] => WP_Post Object
(
[ID] => 5065
[post_author] => 4
[post_date] => 2026-09-01 14:03:32
[post_date_gmt] => 2026-09-01 18:03:32
[post_content] =>
Applications are now open for the 12th BioREACH Award Program from the Center for Biotechnology, which provides $50,000 in translational research funding for Stony Brook faculty and postdoctoral researchers to generate the evidence needed to advance promising innovations to the next stage of development.
BioREACH funds milestone-driven studies and welcomes biomedical innovations as well as platforms, tools, computational technologies, and other enabling technologies with the potential to contribute to solutions addressing unmet needs in health.
Application deadline: October 29, 2026, 5:00pm ET
For info sessions, eligibility and deadlines visit our REACH Website and FAQ.
The Center for Biotechnology (CfB) has helped advance some of Stony Brook University’s most impactful biomedical innovations, among them the yeast two-hybrid system, Xiaflex®, ReoPro®, Oracea®, and 3D virtual colonoscopy. The CfB has supported more than 475 faculty-led translational research projects and contributed to 306 license agreements generating $51 million in royalty returns to the University.
Questions? Reach out to our program contacts or sign up for office hours:
Dee Dao, PhD, Associate Director, dee.dao@stonybrook.edu
Office Hours: Monday–Friday, 2–3:30 PM | Sign up Here
Zelda Mendelowitz, PhD, Venture Associate, zelda.mendelowitz@stonybrook.edu
Office Hours: Tuesday, Wednesday, Friday, 8–11 AM | Sign up Here
[post_title] => BioREACH: Translational Research Funding Opportunity
[post_excerpt] =>
[post_status] => publish
[comment_status] => open
[ping_status] => open
[post_password] =>
[post_name] => bioreach-translational-research-funding-opportunity
[to_ping] =>
[pinged] =>
[post_modified] => 2026-09-04 11:55:36
[post_modified_gmt] => 2026-09-04 15:55:36
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://centerforbiotechnology.org/?p=5065
[menu_order] => 0
[post_type] => post
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[comment_count] => 0
[current_comment] => -1
[found_posts] => 288
[max_num_pages] => 96
[max_num_comment_pages] => 0
[is_single] =>
[is_preview] =>
[is_page] =>
[is_archive] =>
[is_date] =>
[is_year] =>
[is_month] =>
[is_day] =>
[is_time] =>
[is_author] =>
[is_category] =>
[is_tag] =>
[is_tax] =>
[is_search] =>
[is_feed] =>
[is_comment_feed] =>
[is_trackback] =>
[is_home] => 1
[is_privacy_policy] =>
[is_404] =>
[is_embed] =>
[is_paged] =>
[is_admin] =>
[is_attachment] =>
[is_singular] =>
[is_robots] =>
[is_favicon] =>
[is_posts_page] =>
[is_post_type_archive] =>
[query_vars_hash:WP_Query:private] => 325c4f9f1aebaa5ec90666fa54175ba0
[query_vars_changed:WP_Query:private] =>
[thumbnails_cached] =>
[allow_query_attachment_by_filename:protected] =>
[stopwords:WP_Query:private] =>
[compat_fields:WP_Query:private] => Array
(
[0] => query_vars_hash
[1] => query_vars_changed
)
[compat_methods:WP_Query:private] => Array
(
[0] => init_query_flags
[1] => parse_tax_query
)
[query_cache_key:WP_Query:private] =>
)